Skip to main content

Vanda Pharmaceuticals Inc.

VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001347178

No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Vanda Pharmaceuticals Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Vanda Pharmaceuticals Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Vanda Pharmaceuticals Inc.
NameTitleLast reported holdingLast filingFilings, past year
Dugan Richard WDirector219,054Jun 8, 20261
Chrousos PhaedraDirector164,950Jun 8, 20261
Ward Anne SempowskiDirector160,667Jun 8, 20261
Mitchell Stephen RayDirector112,846Jun 8, 20262
Honore TageDirector135,069Jun 8, 20262
Duncan Charles CliffDirector98,701Jun 8, 20262
McGuire Daniel PatrickSVP, GC and Secretary109,982Jun 8, 20261
Polymeropoulos Mihael HristosPresident and CEO2,704,496Mar 4, 20262
Birznieks GuntherSVP, Business Development494,197Mar 4, 20262
Williams TimothySVP & General Counsel377,450Mar 4, 20262
Wijkstrom JoakimSVP, Chief Marketing Officer333,469Mar 4, 20262
Moran Kevin PatrickSVP, CFO & Treasurer411,380Mar 4, 20262
Watkins ThomasDirector63,064Jun 3, 20220
Jones Aranthan IIChief Corp. Affairs Officer81,980Sep 17, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 4, 2026 (view filing)Mar 22 daysMoran Kevin PatrickSVP, CFO & TreasurerSSale−42.4K$8.27−$351.0K−9.4%411.4K after
Mar 4, 2026 (view filing)Mar 22 daysWijkstrom JoakimSVP, Chief Marketing OfficerSSale−30.8K$8.27−$254.7K−8.5%333.5K after
Mar 4, 2026 (view filing)Mar 22 daysWilliams TimothySVP & General CounselSSale−42.4K$8.27−$350.9K−10.1%377.4K after
Mar 4, 2026 (view filing)Mar 22 daysBirznieks GuntherSVP, Business DevelopmentSSale−42.4K$8.27−$350.9K−7.9%494.2K after
Mar 4, 2026 (view filing)Mar 22 daysPolymeropoulos Mihael HristosPresident and CEOSSale−156.2K$8.17−$1.28M−5.5%2.70M after
Feb 24, 2026 (view filing)Feb 231 dayHonore TageDirectorSSale−30.0K$8.03−$240.9K−24.3%93.5K after
Aug 8, 2025 (view filing)Aug 71 dayPolymeropoulos Mihael HristosPresident and CEOPPurchase+10.0K$4.15+$41.5K+0.4%2.34M after
Jun 16, 2025 (view filing)Jun 133 daysMitchell Stephen RayDirectorSSale−7.00K$4.59−$32.1K−6.7%97.1K after
May 21, 2025 (view filing)May 21Same dayPolymeropoulos Mihael HristosPresident and CEOPPurchase+10.0K$4.40+$44.0K+0.4%2.33M after2 lots
May 19, 2025 (view filing)May 163 daysPolymeropoulos Mihael HristosPresident and CEOPPurchase+20.0K$4.22+$84.4K+0.9%2.32M after
Mar 6, 2025 (view filing)Mar 6Same dayPolymeropoulos Mihael HristosPresident and CEOPPurchase+10.0K$5.02+$50.1K+0.4%2.30M after2 lots
Mar 5, 2025 (view filing)Mar 5Same dayPolymeropoulos Mihael HristosPresident and CEOPPurchase+10.0K$5.02+$50.2K+0.4%2.29M after2 lots
Mar 4, 2025 (view filing)Mar 31 dayPolymeropoulos Mihael HristosPresident and CEOPPurchase+10.0K$4.71+$47.1K+0.4%2.28M after
Feb 28, 2025 (view filing)Feb 28Same dayPolymeropoulos Mihael HristosPresident and CEOPPurchase+10.0K$4.76+$47.6K+0.4%2.36M after
Feb 27, 2025 (view filing)Feb 27Same dayPolymeropoulos Mihael HristosPresident and CEOPPurchase+10.0K$4.76+$47.6K+0.4%2.35M after
Feb 26, 2025 (view filing)Feb 26Same dayPolymeropoulos Mihael HristosPresident and CEOPPurchase+10.0K$4.77+$47.6K+0.4%2.34M after2 lots
Feb 25, 2025 (view filing)Feb 25Same dayPolymeropoulos Mihael HristosPresident and CEOPPurchase+10.0K$4.46+$44.6K+0.4%2.33M after
Feb 24, 2025 (view filing)Feb 213 daysMoran Kevin PatrickSVP, CFO & TreasurerPPurchase+2.00K$4.39+$8.78K+0.6%355.8K after
Nov 18, 2024 (view filing)Nov 144 daysMitchell Stephen RayDirectorSSale−5.00K$5.17−$25.9K−10.0%44.9K after
Jul 29, 2024 (view filing)Jul 29Same dayMoran Kevin PatrickSVP, CFO & TreasurerSSale−2.25K$5.92−$13.3K−1.0%228.8K after
Mar 6, 2024 (view filing)Mar 4-52 daysWilliams TimothySVP & General CounselSSale−17.1K$4.29−$73.3K−8.0%196.8K after2 lots
Mar 6, 2024 (view filing)Mar 4-52 daysWijkstrom JoakimSVP, Chief Marketing OfficerSSale−16.7K$4.30−$71.9K−11.4%129.8K after2 lots
Mar 6, 2024 (view filing)Mar 4-52 daysPolymeropoulos Mihael HristosPresident and CEOSSale−55.2K$4.19−$231.3K−2.9%1.87M after2 lots
Mar 6, 2024 (view filing)Mar 4-52 daysMoran Kevin PatrickSVP, CFO & TreasurerSSale−14.7K$4.31−$63.4K−6.0%231.0K after2 lots
Mar 6, 2024 (view filing)Mar 4-52 daysBirznieks GuntherSVP, Business DevelopmentSSale−17.4K$4.22−$73.4K−5.3%313.6K after2 lots
Aug 23, 2023 (view filing)Aug 212 daysWijkstrom JoakimSVP, Chief Marketing OfficerSSale−3.72K$5.84−$21.7K−3.2%113.8K after
Aug 11, 2023 (view filing)Aug 101 dayMitchell Stephen RayDirectorSSale−6.50K$6.05−$39.3K−18.1%29.3K after
Aug 1, 2023 (view filing)Jul 284 daysMoran Kevin PatrickSVP, CFO & TreasurerSSale−2.21K$6.31−$14.0K−1.8%120.7K after2 lots
Jun 20, 2023 (view filing)Jun 155 daysMoran Kevin PatrickSVP, CFO & TreasurerSSale−16.0K$6.29−$100.6K−11.5%122.9K after
Jun 15, 2023 (view filing)Jun 132 daysWilliams TimothySVP & General CounselSSale−14.6K$6.56−$95.8K−14.1%88.9K after
Mar 6, 2023 (view filing)Mar 2-34 daysWilliams TimothySVP & General CounselSSale−16.7K$6.24−$104.5K−13.9%103.5K after2 lots
Mar 6, 2023 (view filing)Mar 2-34 daysWijkstrom JoakimSVP, Chief Marketing OfficerSSale−11.8K$6.26−$74.1K−9.1%117.5K after2 lots
Mar 6, 2023 (view filing)Mar 2-34 daysPolymeropoulos Mihael HristosPresident and CEOSSale−45.0K$6.24−$280.6K−3.0%1.48M after2 lots
Mar 6, 2023 (view filing)Mar 2-34 daysMoran Kevin PatrickSVP, CFO & TreasurerSSale−13.9K$6.27−$87.3K−9.1%138.9K after2 lots
Mar 6, 2023 (view filing)Mar 2-34 daysBirznieks GuntherSVP, Business DevelopmentSSale−16.8K$6.23−$104.5K−7.5%206.0K after2 lots
Dec 16, 2022 (view filing)Dec 151 dayWilliams TimothySVP & General CounselSSale−8.00K$7.01−$56.1K−8.4%87.6K after
Dec 7, 2022 (view filing)Dec 5-62 daysPolymeropoulos Mihael HristosPresident and CEOSSale−95.9K$10.61−$1.02M−6.4%1.41M after2 lots
Dec 7, 2022 (view filing)Dec 61 dayMoran Kevin PatrickSVP, CFO & TreasurerSSale−4.79K$10.61−$50.8K−3.8%120.2K after
Aug 23, 2022 (view filing)Aug 221 dayWijkstrom JoakimSVP, Chief Marketing OfficerSSale−3.60K$10.27−$37.0K−3.6%96.7K after
Aug 17, 2022 (view filing)Aug 152 daysWilliams TimothySVP & General CounselSSale−8.30K$10.30−$85.5K−8.0%95.6K after2 lots
Aug 1, 2022 (view filing)Jul 284 daysMoran Kevin PatrickSVP, CFO & TreasurerSSale−2.24K$10.97−$24.6K−1.9%117.5K after
Jun 14, 2022 (view filing)Jun 131 dayMitchell Stephen RayDirectorSSale−2.70K$9.48−$25.6K−29.3%6.51K after
Jun 3, 2022 (view filing)Jun 21 dayWatkins ThomasDirectorSSale−6.44K$9.90−$63.8K−9.3%63.1K after
Jun 2, 2022 (view filing)May 312 daysDugan Richard WDirectorSSale−6.50K$9.85−$64.0K−8.7%68.4K after
Mar 2, 2022 (view filing)Mar 2Same dayWilliams TimothySVP & General CounselSSale−12.1K$11.09−$133.7K−10.4%103.9K after
Mar 2, 2022 (view filing)Mar 2Same dayWijkstrom JoakimSVP, Chief Marketing OfficerSSale−6.97K$11.19−$78.0K−6.5%100.3K after
Mar 2, 2022 (view filing)Mar 1-21 dayPolymeropoulos Mihael HristosPresident and CEOSSale−37.1K$11.16−$413.9K−2.7%1.35M after2 lots
Mar 2, 2022 (view filing)Mar 1-21 dayMoran Kevin PatrickSVP, CFO & TreasurerSSale−12.3K$11.25−$138.5K−9.3%119.7K after2 lots
Mar 2, 2022 (view filing)Mar 1-21 dayBirznieks GuntherSVP, Business DevelopmentSSale−15.6K$11.25−$175.5K−7.6%188.8K after2 lots
Dec 2, 2021 (view filing)Nov 30-Dec 12 daysPolymeropoulos Mihael HristosPresident and CEOSSale−96.2K$16.25−$1.56M−7.0%1.27M after2 lots